SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-06-03 14:53
Tx date 2026-06-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Options
70 - Acquisition or disposition (writing) of third party derivative 		$8,250
+5,000 vol
$1.65 each 		5,000
Filed 2026-06-03 14:51
Tx date 2024-09-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-06-03 14:51
Tx date 2026-06-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Options
70 - Acquisition or disposition (writing) of third party derivative 		$8,250
+5,000 vol
$1.65 each 		5,000
Filed 2026-06-03 13:36
Tx date 2024-09-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-06-03 12:32
Tx date 2026-06-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,573,870
+103,002 vol
$15.28 each 		274,811
Filed 2026-06-03 12:30
Tx date 2026-06-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$751.66
+49 vol
$15.34 each 		171,809
Filed 2026-06-03 12:30
Tx date 2026-06-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$2,624,492
+171,760 vol
$15.28 each 		171,760
Filed 2026-06-03 12:28
Tx date 2024-09-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2026-06-03 12:27
Tx date 2026-06-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,573,885
+103,003 vol
$15.28 each 		324,814
Filed 2026-06-03 12:26
Tx date 2026-06-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$767.00
+50 vol
$15.34 each 		221,811
Filed 2026-06-03 12:24
Tx date 2026-06-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$2,624,508
+171,761 vol
$15.28 each 		221,761
Filed 2026-06-03 12:23
Tx date 2026-05-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
Common Shares
97 - Other
+50,000 vol 		50,000
Filed 2026-06-03 12:21
Tx date 2026-05-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
Common Shares
97 - Other
-50,000 vol 		7,205,442
Filed 2026-06-03 12:17
Tx date 2026-05-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$4,021,661
+262,682 vol
$15.31 each 		7,255,442
Filed 2026-06-03 12:13
Tx date 2026-05-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$35,289
+2,299 vol
$15.35 each 		6,992,760
Filed 2026-03-04 14:06
Tx date 2026-03-03 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$818,574
+57,565 vol
$14.22 each 		5,239,039
Filed 2026-03-04 14:05
Tx date 2026-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$514,188
+36,185 vol
$14.21 each 		5,181,474
Filed 2026-03-04 14:05
Tx date 2026-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$374,199
+26,113 vol
$14.33 each 		5,145,289
Filed 2026-03-04 14:04
Tx date 2026-02-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$7,190
+500 vol
$14.38 each 		5,119,176
Filed 2026-03-04 14:04
Tx date 2026-02-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$947,974
+67,137 vol
$14.12 each 		5,118,676